Andrew Grigore Buzdugan

Andrew Grigore Buzdugan is a seasoned finance professional specializing in planning and analytics. Currently serving as a Senior Finance Manager at Melinta Therapeutics since March 2018, Andrew enhances strategic planning, budgeting, and forecasting through collaboration with various business units. Previous roles include Finance Manager, focusing on market and product analytics, and Senior Financial Analyst at Shire, where Andrew spearheaded process improvements in revenue recognition and managed gross-to-net accounting. Early career experiences include financial reporting at Cancer Treatment Centers of America and sales analysis at Suzo-Happ. Andrew holds a Bachelor of Science in Finance from Babes-Bolyai University and has a background in technical education from Technical University of Cluj Napoca.